GPT Healthcare Ltd reports Q2 net profit of ₹15.40 crore, up 45.3% year on year, and declares ₹1 interim dividend
- Revenue from operations was ₹135.62 crore, up 14.1% YoY and 7.5% sequentially.
- EBITDA stood at ₹26.88 crore; margin was 19.8%, versus 19.2% in Q1.
- Record date for the interim dividend is November 12, 2026; limited review conclusion was unmodified.